- Home
- ZLAB vs PTCT Comparison
ZLAB vs PTCT Comparison
Compare ZLAB & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- PTCT
- Stock Information
- Founded
- ZLAB 2013
- PTCT 1998
- Country
- ZLAB China
- PTCT United States
- Employees
- ZLAB N/A
- PTCT N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- ZLAB Health Care
- PTCT Health Care
- Exchange
- ZLAB Nasdaq
- PTCT Nasdaq
- Market Cap
- ZLAB 3.6B
- PTCT 3.9B
- IPO Year
- ZLAB 2017
- PTCT 2013
- Fundamental
- Price
- ZLAB $34.28
- PTCT $49.46
- Analyst Decision
- ZLAB Buy
- PTCT Buy
- Analyst Count
- ZLAB 5
- PTCT 14
- Target Price
- ZLAB $54.28
- PTCT $63.57
- AVG Volume (30 Days)
- ZLAB 718.6K
- PTCT 1.1M
- Earning Date
- ZLAB 08-05-2025
- PTCT 08-07-2025
- Dividend Yield
- ZLAB N/A
- PTCT N/A
- EPS Growth
- ZLAB N/A
- PTCT N/A
- EPS
- ZLAB N/A
- PTCT 7.51
- Revenue
- ZLAB $418,326,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- ZLAB $44.07
- PTCT $121.37
- Revenue Next Year
- ZLAB $49.13
- PTCT N/A
- P/E Ratio
- ZLAB N/A
- PTCT $6.58
- Revenue Growth
- ZLAB 43.72
- PTCT 91.12
- 52 Week Low
- ZLAB $16.01
- PTCT $29.02
- 52 Week High
- ZLAB $44.34
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- ZLAB 46.71
- PTCT 51.78
- Support Level
- ZLAB $32.31
- PTCT $48.05
- Resistance Level
- ZLAB $35.72
- PTCT $49.73
- Average True Range (ATR)
- ZLAB 1.12
- PTCT 1.44
- MACD
- ZLAB -0.46
- PTCT -0.11
- Stochastic Oscillator
- ZLAB 33.62
- PTCT 64.98
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.